MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates (PWML)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02637817|
Recruitment Status : Recruiting
First Posted : December 22, 2015
Last Update Posted : August 10, 2016
|Condition or disease|
|Brain Diseases Amblyopia Brain Damage, Chronic Cerebral Palsy|
|Study Type :||Observational|
|Estimated Enrollment :||600 participants|
|Official Title:||MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study|
|Study Start Date :||January 2016|
|Estimated Primary Completion Date :||June 2019|
Neonates with no evidence of brain lesions on conventional MRI.
Neonates with PWML diagnosed by conventional MRI.
- Cerebral Palsy [ Time Frame: At age 2 ]The enrolled subjects who will be diagnosed as cerebral palsy by clinical examination at age 2.
- Amblyopia or movement disorder [ Time Frame: At age 3 ]The enrolled subjects who will be diagnosed as amblyopia or movement disorder by clinical examination at age 3.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02637817
|Contact: Jian Yang, Ph.D.,M.D.||+email@example.com|
|First Affiliated Hospital of Xi'an Jiaotong University||Recruiting|
|Xi'an, Shaanxi, China|
|Contact: Jian Yang, Ph.D.,M.D. +8618991232396 firstname.lastname@example.org|